The company is scheduling one-to-one investor meetings as part of its investor relations activities.
The meetings are scheduled for September 22, 2026 and will be conducted in physical mode at Mumbai.
The purpose of the meetings is to interact with investors, though no specific discussion topics are mentioned beyond referencing available materials.
The company explicitly states that no unpublished price sensitive information (UPSI) will be shared during these interactions.
Management participants are not specifically named, referred to only as "officials" of the company.
Relevant press releases and investor presentations proposed to be discussed are available on the company website (www.fermentabiotech.com) and stock exchange portals.
No financial data, guidance references, or presentation summaries were included in this intimation notice.
Additional Notes Section
This is a regulatory filing made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The document includes a digital signature from Varadvinayak Vijay Khambete, Company Secretary & Head - Legal.
The company notes that changes may occur due to exigencies on the part of the company or investors.
No financial data or performance figures were disclosed in this announcement.
